Ngā hua rapu - Samuel Datum Moscavitch

  • E whakaatu ana i te 1 - 10 hua o te 10
Whakamahine hua
  1. 1
    Probiotic therapy with Saccharomyces boulardii for heart failure patients: A randomized, double-blind, placebo-controlled pilot trial

    Probiotic therapy with Saccharomyces boulardii for heart failure patients: A randomized, double-blind, placebo-controlled pilot trial mā Annelise C. Costanza, Samuel Datum Moscavitch, Hugo Caire Castro-Faria Neto, Evandro Tinoco Mesquita

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    The Use of Two-Dimensional Strain Measured by Speckle Tracking in the Identification of Incipient Ventricular Dysfunction in HIV-Infected Patients on Antiretroviral Therapy, Untreated HIV Patients and Healthy Controls

    The Use of Two-Dimensional Strain Measured by Speckle Tracking in the Identification of Incipient Ventricular Dysfunction in HIV-Infected Patients on Antiretroviral Therapy, Untrea... mā Ronaldo Campos Rodrigues, Kátia Martins Lopes de Azevedo, Samuel Datum Moscavitch, Sérgio Setúbal, Cláudio Tinoco Mesquita

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Variação sazonal nas hospitalizações por insuficiência cardíaca em Niterói, RJ

    Variação sazonal nas hospitalizações por insuficiência cardíaca em Niterói, RJ mā José Eduardo Jorge, Maurício Cagy, Evandro Tinoco Mesquita, Thiago Costa, Samuel Datum Moscavitch, Maria Luiza Garcia Rosa

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Comparison of adipokines in a cross-sectional study with healthy overweight, insulin-sensitive and healthy lean, insulin-resistant subjects, assisted by a family doctor primary care program

    Comparison of adipokines in a cross-sectional study with healthy overweight, insulin-sensitive and healthy lean, insulin-resistant subjects, assisted by a family doctor primary car... mā Samuel Datum Moscavitch, Hye Chung Kang, Rubens Antunes da Cruz Filho, Evandro Tinoco Mesquita, Hugo Castro-Faria Neto, Maria Luiza Garcia Rosa

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Uso inapropriado da ecocardiografia transtorácica, segundo recomendações da SBC

    Uso inapropriado da ecocardiografia transtorácica, segundo recomendações da SBC mā Laiz Boniziolli Barachi, Flávia Candolo Pupo Barbosa, Samuel-Datum Moscavitch, Barbara Pilon, Gabriela Vescovi Pissinati, Evandro Tinoco Mesquita, Cláudio Tinoco Mesquita, Marcus Vinicius Santos

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure

    Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure mā Andraž Nendl, Sajan C. Raju, Kaspar Broch, Cristiane C.K. Mayerhofer, Kristian Holm, Bente Halvorsen, Knut Tore Lappegård, Samuel Datum Moscavitch, Johannes R. Hov, Ingebjørg Seljeflot, Marius Trøseid, Ayodeji Awoyemi

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Cardiac I123-MIBG Correlates Better than Ejection Fraction with Symptoms Severity in Systolic Heart Failure

    Cardiac I123-MIBG Correlates Better than Ejection Fraction with Symptoms Severity in Systolic Heart Failure mā Sandra Marina Miranda, Samuel Datum Moscavitch, Larissa R. Carestiato, R Felix, Ronaldo Campos Rodrigues, Leandro Rocha Messias, Jader Cunha de Azevedo, Antônio Cláudio Lucas da Nóbrega, Evandro Tinoco Mesquita, Cláudio Tinoco Mesquita

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial

    Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial mā Cristiane C.K. Mayerhofer, Ayodeji Awoyemi, Samuel Datum Moscavitch, Knut Tore Lappegård, Johannes R. Hov, Pål Aukrust, Anders Hovland, Andrea De Lorenzo, Sigrun Halvorsen, Ingebjørg Seljeflot, Lars Gullestad, Marius Trøseid, Kaspar Broch

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Evaluation of Quality of Life in Patients with and without Heart Failure in Primary Care

    Evaluation of Quality of Life in Patients with and without Heart Failure in Primary Care mā Antônio José Lagoeiro Jorge, Maria Luiza Garcia Rosa, Dayse Mary da Silva Correia, Wolney de Andrade Martins, Diana Martínez, Leonardo Chaves Ferreira Coelho, William Shinji Nobre Soussume, Hye Chung Kang, Samuel Datum Moscavitch, Evandro Tinoco Mesquita

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial

    Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial mā Ayodeji Awoyemi, Cristiane C.K. Mayerhofer, Alex S. Felix, Johannes R. Hov, Samuel Datum Moscavitch, Knut Tore Lappegård, Anders Hovland, Sigrun Halvorsen, Bente Halvorsen, Ida Gregersen, Asbjørn Svardal, Rolf K. Berge, Simen H. Hansen, Alexandra Götz, Kristian Holm, Pål Aukrust, Sissel Åkra, Ingebjørg Seljeflot, Svein Solheim, Andrea De Lorenzo, Lars Gullestad, Marius Trøseid, Kaspar Broch

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: